Investing Ideas
/
Hungarian Pharmaceuticals & Biotech High Return On Equity, Low Debt

Hungarian Pharmaceuticals & Biotech High Return On Equity, Low Debt

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag

Market Cap: Ft38.7b

NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag produziert und vertreibt pharmazeutische Produkte in Ungarn.

NATURLAND

Ft2,800.00

-0.7%

7.7%